Co-Diagnostics, Inc..
CODX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets diagnostic solutions. It primarily focuses on the detection of infectious diseases, including COVID-19, and other conditions. The company's products include PCR (polymerase chain reaction) tests, reagent...Show More
Better Health for All
30
Co-Diagnostics' core business is the development and manufacture of diagnostic tests for infectious diseases such as COVID-19, tuberculosis, malaria, hepatitis B, hepatitis C, HPV, HIV, syphilis, Zika, dengue, and chikungunya.
1
These products provide substantial health benefits, with no evidence of negative health impacts. During the COVID-19 pandemic, the company developed a PCR COVID-19 assay, which received CE marking on February 24, 2020, and FDA Emergency Use Authorization, demonstrating 100% sensitivity and specificity in independent evaluations.
2
The company also trained Dare Labs employees in Ghana in molecular diagnostics.
3
However, the company withdrew a 510(k) submission for a COVID-19 assay in February 2025.
4
Fair Money & Economic Opportunity
0
No evidence available to assess Co-Diagnostics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantitative data points were found across the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median employee pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, insecure contract share, or health insurance coverage was not explicitly stated with concrete numbers or percentages.
1
While some articles mentioned a lack of regulatory actions or violations,
2
this is an absence of evidence rather than evidence of a specific performance tier for labor violation incidents.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Co-Diagnostics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-30
Co-Diagnostics, Inc. received a $250,000 fine and a cease-and-desist order from the SEC for issuing materially misleading press releases regarding COVID-19 tests and for failing to disclose related-party transactions, including significant payments to family members of executives.
1
The company has a whistleblower policy, revised in March 2017, which includes an ethics hotline managed by an external vendor, intranet reporting, and a prohibition against retaliation.
2
Initial reports are reviewed within 48 business hours, investigated, and resolved with communication to the Audit Committee.
3
The anti-corruption policy covers fraud, embezzlement, conflicts of interest, and compliance with laws like the Foreign Corrupt Practices Act;
4
however, the company's failure to disclose related-party transactions indicates a significant lapse in enforcement or due diligence. Independent auditors are selected, retained, and compensated, with annual evaluations of their qualifications, performance, and independence, but the extent of independent verification of ethical claims beyond this is not specified.
5
Kind to Animals
0
No specific, concrete data points were found in the provided articles regarding Co-Diagnostics, Inc.'s practices or policies related to animal welfare, animal testing, animal-derived ingredients, or wildlife conservation. The articles discuss the broader market for companion animal diagnostics and non-animal alternative testing, as well as general information about cruelty-free certifications and other companies' policies, but do not contain any direct evidence for CODX.US against the defined KPIs.
No War, No Weapons
0
No evidence available to assess Co-Diagnostics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles primarily focus on the company's financial performance, product developments, and market expansion. They do not contain any specific, concrete data points or information related to environmental stewardship, carbon emissions, renewable energy, water usage, waste management, green building certifications, supply chain climate impacts, biodiversity efforts, deforestation policies, environmental compliance violations, environmental impact assessments, climate targets, TCFD alignment, climate scenario analysis, stranded assets, packaging, or climate justice initiatives.
1
Therefore, no KPIs under the 'Planet-Friendly Business' value can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No evidence available to assess Co-Diagnostics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Co-Diagnostics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
-20
The company achieved a 68% recycling rate at its Salt Lake City facility.
1
Additionally, it reduced single-use plastic by 42%.
2